FDA Drug Application (021882) for EXJADE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021882
Product Number001
FormTABLET, FOR SUSPENSION;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXJADE
Active IngredientDEFERASIROX

Active IngredientCount
List of drugs with Active Ingredient DEFERASIROX3


Back to FDA Applications sponsored by NOVARTIS